TickerFacts.

Becton Dickinson & Co (BDX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2008-09-30, 2010-09-30, 2017-09-30, 2020-09-30 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$5.04B
Year ended 2025-09-30
+3.8%
3-year compound annual growth
+10.7%
5-year compound annual growth
2007-09-30: $1.63B2008-09-30: $1.96B2009-09-30: $2.05B2010-09-30: $2.07B2011-09-30: $2.16B2012-09-30: $2.07B2013-09-30: $1.80B2014-09-30: $2.17B2015-09-30: $1.97B2016-09-30: $2.54B2017-09-30: $2.61B2018-09-30: $3.49B2019-09-30: $4.01B2020-09-30: $3.03B2021-09-30: $4.48B2022-09-30: $4.51B2023-09-30: $4.40B2024-09-30: $4.68B2025-09-30: $5.04B$5.04B
2007-09-30 EBITDA (USD) 2025-09-30
Period endedEBITDAChange YoYSource filing
2025-09-30$5.04B+7.6%2025-11-25, From 2024-10-01
2024-09-30$4.68B+6.5%2025-11-25, From 2023-10-01
2023-09-30$4.40B-2.5%2025-11-25, From 2022-10-01
2022-09-30$4.51B+0.7%2024-11-27, From 2021-10-01
2021-09-30$4.48B+48.0%2023-11-21, From 2020-10-01
2020-09-30$3.03Bn/c2022-11-22, From 2019-10-01
2019-09-30$4.01B+15.1%2021-11-24, From 2018-10-01
2018-09-30$3.49B+33.6%2020-11-25, From 2017-10-01
2017-09-30$2.61Bn/c2019-11-27, From 2016-10-01
2016-09-30$2.54B+29.5%2018-11-21, From 2015-10-01
2015-09-30$1.97B-9.4%2017-11-22, From 2014-10-01
2014-09-30$2.17B+20.4%2016-11-23, From 2013-10-01
2013-09-30$1.80B-13.0%2015-11-25, From 2012-10-01
2012-09-30$2.07B-4.2%2014-11-26, From 2011-10-01
2011-09-30$2.16B+4.2%2013-11-27, From 2010-10-01
2010-09-30$2.07Bn/c2012-11-21, From 2009-10-01
2009-09-30$2.05B+4.8%2011-11-23, From 2008-10-01
2008-09-30$1.96Bn/c2010-11-24, From 2007-10-01
2007-09-30$1.63Bn/a2010-01-21, From 2006-10-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Becton Dickinson & Co (BDX)2025-09-30$5.04B+7.6%
Boston Scientific Corp (BSX)2025-12-31$4.98B+28.6%
3M Co (MMM)2025-12-31$5.94B-4.0%
Stryker Corp (SYK)2025-12-31$6.46B+26.3%
Medline Inc. (MDLN)2025-12-31$3.22B+3.2%
Baxter International Inc (BAX)2025-12-31$673.00M-33.4%
Solventum Corp (SOLV)2025-12-31$2.67B+67.8%
ResMed Inc (RMD)2026-06-30$2.09B+10.8%
Dexcom Inc (DXCM)2025-12-31$1.16B+42.3%

Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗